Dexcom Unveils New Report on Type 2 Diabetes Management in the U.S. at ADA

 

New State of Type 2 Report in the United States reports that a majority of healthcare professionals (HCPs) surveyed believe continuous glucose monitoring will have the potential to be more impactful on the future of Type 2 diabetes care than advancements in diabetes medications.1
Dexcom Warrior Lance Bass will share first-hand experience saying “Bye” to fingersticks* during panel at ADA.

DexCom, Inc., the global leader in glucose biosensing, today released its "Dexcom State of Type 2 Report: Access and Attitudes Across the United States" ahead of the 85th Scientific Sessions of the American Diabetes Association (ADA) in Chicago. The findings provide valuable insights into the perceptions around diabetes technology from more than 400 healthcare professionals and people with Type 2 diabetes across the United States.

https://www.stocktitan.net/news/DXCM/dexcom-unveils-new-report-on-type-2-diabetes-management-in-the-u-s-0zfddzvcu816.html